Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg price in the Philippines
Quick answer
The DOH reference price for Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg is ₱1,750.00 per tablet (median, June 2024 index); drugstore prices are usually higher. FDA Philippines lists 7 registered products at Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg (checked 2026-11-05): 4 as unbranded generics and 3 under 3 brand names. It is a prescription (Rx) medicine. Ask the pharmacist for the unbranded generic of the same strength.
Government reference price
At the DOH median, 30 tablets cost about ₱52,500.00, a month at one a day.
DPRI range, DOH DPRI June 2024. What public hospitals pay; drugstore prices are usually higher.
Registered products
Registered Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg products
FDA Philippines lists 7 registrations under 4 brand names (one row is unbranded generics).
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Acriptega | 300 mg/300 mg/50 mg Film-Coated Tablet | Rx | Mylan Laboratories Limited (India) | 1 |
| Kovatraxx | 50 mg/300 mg/ 300 mg Film-Coated Tablet | Rx | Macleods Pharmaceuticals Limited (India) | 1 |
| Teldy | 50 mg/300 mg/300 mg Film Coated Tablet | Rx | Hetero Labs Limited (India) | 1 |
| No brand (generic) | 50 mg/300 mg/ 300 mg Film-Coated Tablet; 50 mg/300 mg/300 mg Film-Coated Tablet; 50mg/300mg/300mg Film-Coated Tablet | Rx | APL Healthcare Limited, Unit-IV (India) +3 more | 4 |
Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.
Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg: products and brands
Paying less for dolutegravir + lamivudine + tenofovir
- Ask for the generic
Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works
- Senior or PWD card
20% off plus no VAT on your own medicines, with ID and prescription. What to bring
Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.